173 related articles for article (PubMed ID: 32245218)
1. 1
Omar AM; Elfaky MA; Arold ST; Soror SH; Khayat MT; Asfour HZ; Bamane FH; El-Araby ME
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32245218
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography.
Sudo K; Inoue H; Shimizu Y; Yamaji K; Konno K; Shigeta S; Kaneko T; Yokota T; Shimotohno K
Antiviral Res; 1996 Aug; 32(1):9-18. PubMed ID: 8863991
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
Hamill P; Jean F
Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
[TBL] [Abstract][Full Text] [Related]
4. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
[TBL] [Abstract][Full Text] [Related]
5. Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry.
Pillaiyar T; Namasivayam V; Manickam M
Curr Med Chem; 2016; 23(29):3404-3447. PubMed ID: 27160539
[TBL] [Abstract][Full Text] [Related]
6. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease.
Shimizu Y; Yamaji K; Masuho Y; Yokota T; Inoue H; Sudo K; Satoh S; Shimotohno K
J Virol; 1996 Jan; 70(1):127-32. PubMed ID: 8523516
[TBL] [Abstract][Full Text] [Related]
7. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
Tsantrizos YS
Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
[TBL] [Abstract][Full Text] [Related]
9. Synthetic bulky NS4A peptide variants bind to and inhibit HCV NS3 protease.
El-Araby ME; Omar AM; Soror SH; Arold ST; Khayat MT; Asfour HZ; Bamane F; Elfaky MA
J Adv Res; 2020 Jul; 24():251-259. PubMed ID: 32373358
[TBL] [Abstract][Full Text] [Related]
10. The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase.
Attwood MR; Bennett JM; Campbell AD; Canning GG; Carr MG; Conway E; Dunsdon RM; Greening JR; Jones PS; Kay PB; Handa BK; Hurst DN; Jennings NS; Jordan S; Keech E; O'Brien MA; Overton HA; King-Underwood J; Raynham TM; Stenson KP; Wilkinson CS; Wilkinson TC; Wilson FX
Antivir Chem Chemother; 1999 Sep; 10(5):259-73. PubMed ID: 10574181
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease.
Zhu H; Briggs JM
Proteins; 2011 Aug; 79(8):2428-43. PubMed ID: 21633972
[TBL] [Abstract][Full Text] [Related]
12. NS3-4A of hepatitis C virus is a chymotrypsin-like protease.
Hahm B; Han DS; Back SH; Song OK; Cho MJ; Kim CJ; Shimotohno K; Jang SK
J Virol; 1995 Apr; 69(4):2534-9. PubMed ID: 7884903
[TBL] [Abstract][Full Text] [Related]
13. Peptide inhibitors of hepatitis C virus NS3 protease.
Portal-Núñez S; González-Navarro CJ; García-Delgado M; Vizmanos JL; Lasarte JJ; Borrás-Cuesta F
Antivir Chem Chemother; 2003 Sep; 14(5):225-33. PubMed ID: 14694985
[TBL] [Abstract][Full Text] [Related]
14. A novel recombinant single-chain hepatitis C virus NS3-NS4A protein with improved helicase activity.
Howe AY; Chase R; Taremi SS; Risano C; Beyer B; Malcolm B; Lau JY
Protein Sci; 1999 Jun; 8(6):1332-41. PubMed ID: 10386883
[TBL] [Abstract][Full Text] [Related]
15. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
De Francesco R; Pessi A; Steinkühler C
Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus NS3/4A protease.
Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580
[TBL] [Abstract][Full Text] [Related]
17. Evolution, synthesis and SAR of tripeptide alpha-ketoacid inhibitors of the hepatitis C virus NS3/NS4A serine protease.
Colarusso S; Gerlach B; Koch U; Muraglia E; Conte I; Stansfield I; Matassa VG; Narjes F
Bioorg Med Chem Lett; 2002 Feb; 12(4):705-8. PubMed ID: 11844706
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.
Butkiewicz NJ; Wendel M; Zhang R; Jubin R; Pichardo J; Smith EB; Hart AM; Ingram R; Durkin J; Mui PW; Murray MG; Ramanathan L; Dasmahapatra B
Virology; 1996 Nov; 225(2):328-38. PubMed ID: 8918919
[TBL] [Abstract][Full Text] [Related]
19. Highly potent non-peptidic inhibitors of the HCV NS3/NS4A serine protease.
Sperandio D; Gangloff AR; Litvak J; Goldsmith R; Hataye JM; Wang VR; Shelton EJ; Elrod K; Janc JW; Clark JM; Rice K; Weinheimer S; Yeung KS; Meanwell NA; Hernandez D; Staab AJ; Venables BL; Spencer JR
Bioorg Med Chem Lett; 2002 Nov; 12(21):3129-33. PubMed ID: 12372517
[TBL] [Abstract][Full Text] [Related]
20. Screening and identification of bioactive compounds from citrus against non-structural protein 3 protease of hepatitis C virus genotype 3a by fluorescence resonance energy transfer assay and mass spectrometry.
Khan M; Rauf W; Habib FE; Rahman M; Iqbal M
World J Hepatol; 2020 Nov; 12(11):976-992. PubMed ID: 33312423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
